Bioceres Crop Solutions (BIOX) Set to Post Earnings on Thursday

Bioceres Crop Solutions (NASDAQ:BIOX) is expected to be issuing its Q1 2027 resultson Thursday, November 12th. Analysts expect Bioceres Crop Solutions to announce earnings of $0.02 per share for the quarter. Investors may visit the company’s upcoming Q1 2027 earnings report page for the latest details on the call scheduled for Thursday, November 12, 2026 at 8:30 AM ET.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its quarterly earnings data on Tuesday, September 15th. The company reported ($0.39) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by ($0.33). Bioceres Crop Solutions had a negative return on equity of 39.11% and a negative net margin of 94.76%. The business had revenue of $55.90 million during the quarter, compared to analysts’ expectations of $79.00 million.

Bioceres Crop Solutions Price Performance

NASDAQ BIOX opened at $0.25 on Thursday. The company has a debt-to-equity ratio of 0.94, a current ratio of 0.81 and a quick ratio of 0.63. The stock’s 50-day moving average is $0.34 and its two-hundred day moving average is $0.46. The firm has a market cap of $16.17 million, a P/E ratio of -0.07 and a beta of 0.54. Bioceres Crop Solutions has a fifty-two week low of $0.19 and a fifty-two week high of $2.03.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Bioceres Crop Solutions in a report on Friday, October 9th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Reduce” and an average target price of $2.00.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp. is an Argentina-based agricultural biotechnology company focused on developing technologies that improve crop productivity, resilience and sustainability. The company serves farmers and agricultural businesses through products designed to support crop establishment, nutrition, protection and performance under challenging environmental conditions.

Its portfolio includes the HB4 biotechnology platform, which is used in drought-tolerant wheat and soybean varieties, as well as biological seed treatments, microbial inoculants, biofertilizers, biostimulants and biological crop-protection products.